Biomarker-based treatment matching that surfaces the options most likely to help a specific patient.
Consented intake · your records travel with you · nothing moves without your sign-off
CRI supports biomarker-drug matching for cancer treatment decisions. Starting from the disease profile in a patient's test data, it helps identify treatment options with the most likely effective response. It is for patients who want treatment ideas drawn from the best global thinking, with predictions of treatment response and an assessment of confidence in the expected outcome.
The fastest way to know what you'll pay: check your coverage with your plan. Below is what we know about how CRI? handles billing.
We don't have confirmed insurance details for CRI? yet. Start a coverage check with your plan, or contact the provider directly.
Answers grounded in CRI?'s details here. Educational only; your oncologist directs treatment.
Powered by Navis on opencancer.ai
Other providers in similar categories.
Provide a trusted medical context for personalized experiments; contribute to research that will benefit others and hope that new treatments will be identified in time that may help me.
FoundationOne CDx is an FDA-approved comprehensive genomic profiling test that analyzes 324 genes to identify clinically relevant genomic alterations.
Tempus xT is a comprehensive genomic profiling test combining DNA and RNA sequencing to identify actionable mutations.
Finds clinical trials you actually qualify for — matched to your tumor's biomarkers and treatment history, not a generic keyword search.
This page is general information. Upload your records for analysis specific to YOUR diagnosis.